Home Updates ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities
Update

ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities

  March 31, 2008 at 5:38 pm

ACT-AD urged House and Senate Appropriations Subcommittee leadership to increase funds for FDA drug review activities in FY 2009.
Read Letter

File Attachments
  actadletter (1M PDF)
Categories:
Uncategorized
  Recent Updates
Featured Image
ACT-AD Member Spotlight: BrightFocus Foundation
November 25, 2019
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
October 31, 2018
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
June 15, 2018
Researchers Reverse Alzheimer’s Disease in Mouse Models
February 10, 2018
  Newsletter Signup